malondialdehyde has been researched along with 3,4-dihydroxyphenylacetaldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, DG; Doorn, JA; Florang, VR; Rees, JN | 1 |
| Anderson, DG; Doorn, JA; Florang, VR; Jinsmaa, Y; Rees, JN; Strack, S | 1 |
2 other study(ies) available for malondialdehyde and 3,4-dihydroxyphenylacetaldehyde
| Article | Year |
|---|---|
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; Animals; Corpus Striatum; Cross-Linking Reagents; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Inhibitors; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Synaptosomes | 2007 |
Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Reductase; Aldehydes; Animals; Dopamine; Lipid Peroxidation; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Rats | 2009 |